Peri-operative Oral Pain Control Following Buccal Graft Urethroplasty
Part of paid clinical trials in San Francisco, California.
- Sponsor
- University of California, San Francisco
- Study ID
- NCT05300685
- Phase
- PHASE3
- Status
- Recruiting
Conditions
- Urethral Stricture, Male
Eligibility Criteria
- Sex
- MALE
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Standard Buccal Harvest — DRUGOur institutions current anesthetic regimen. Comparison group
- Basic buccal procedure + Long acting local — DRUGAddition of long-acting local anesthetic to the wound bed following the oral graft harvest.
- Basic buccal procedure + Buccal block — DRUGAddition of long-acting local anesthetic as a buccal block after oral graft harvest
Study Details
Patients undergoing buccal urethroplasty will often have significant post-operative oral pain from the graft site. Various graft harvest techniques and methods for post-harvest hemostasis including graft site closure have been explored. Despite the frequency of this clinical scenario there is no established best practice for peri-operative pain management in this patient population. In addition to traditional post operative pain control, groups have sought various peri-operative anesthetic regimens to improve post operative pain. This has led recently to the description of various regional blocks including buccal and periorbital blocks for peri-operative local anesthetic. No study has looked at superiority of regional pain management in this patient population. This study will aim to assess three established anesthetic protocols for oral pain control in a blinded, randomized controlled trial. Hypothesis: Patients who have buccal block will have lower post op pain without any increase adverse oral outcomes.
Key Dates
- Start date
- Feb 15, 2022
- Status verified
- Jun 2026
- Primary completion
- Jul 1, 2026
- Completion
- Jul 1, 2026
Study Design
- Enrollment
- 60 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Active Comparator: Group 1: Standard of care1. Prior to graft harvest - infiltration of 1% lidocaine with 1:100,000 epinephrine up to a maximum of 10 mL 2. Routine, standard graft site hemostasis with monopolar cautery 3. No suture closure of graft site 4. No further infiltration of local anesthetic in mouth
- Experimental: Group 2: Standard of care + Long acting local1. Prior to graft harvest - infiltration of 1% lidocaine with 1:100,000 epinephrine up to a maximum of 10 mL 2. Routine, standard graft site hemostasis with monopolar cautery 3. No suture closure of graft site 4. Up to a maximum of 10mL of 0.5% bupivacaine infiltration in the buccal graft site
- Experimental: Group 3: Standard of care + Buccal block1. Prior to graft harvest - infiltration of 1% lidocaine with 1:100,000 epinephrine up to a maximum of 10 mL 2. Routine, standard graft site hemostasis with monopolar cautery 3. No suture closure of graft site 4. Up to a maximum of 10mL of 0.5% bupivacaine infiltration as a buccal block
Primary Outcome Measure
Change(s) in Post-operative pain [ Time Frame: Postoperative Day 1, 5, 10 ]
Central Contacts
- Lindsay A Hampson, MD415-353-2200
- Sara Z Amare, BS(415) 514-7597
Locations (2)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| University of California San Francisco | San Francisco | California | 94143 | Nathan M Shaw, MD (SUB_INVESTIGATOR) Lindsay A Hampson, MD (PRINCIPAL_INVESTIGATOR) Benjamin N Breyer, MD (SUB_INVESTIGATOR) |
| MedStar Urology | Washington D.C. | District of Columbia | 20037 |